Froome critical of cycling boss for speaking of failed drugs test

British cyclist competing at Italy’s Tirreno-Adriatico, his second race since test became public

 Chris Froome of Sky Team attending a press conference ahead of the Tirreno-Adriatico   race in  Italy. Photograph: EPA/Dario Belingheri

Chris Froome of Sky Team attending a press conference ahead of the Tirreno-Adriatico race in Italy. Photograph: EPA/Dario Belingheri

 

Chris Froome has criticised the head of cycling’s world governing body for speaking publicly about his 2017 failed drugs test.

The four-times Tour de France winner defended his decision to continue to compete while he challenges an adverse finding from the Vuelta a Espana last September, which indicated double the permitted level of the asthma drug salbutamol in his system.

Froome is competing at the Tirreno-Adriatico in Italy, his second race since the failed test was made public by the Guardian and Le Monde. He plans to ride at the Giro d’Italia in May, before attempting to win a fifth Tour de France.

Union Cycliste Internationale (UCI) president David Lappartient said this week it would damage the credibility of the sport if Froome rode the Tour while his case was unresolved.

“That would be a disaster for the image of cycling,” Lappartient said. “[From] a legal point of view he has the right to ride. For the image of our sport that could be a disaster, and I don’t want to put our sport in trouble.”

However, Froome hit back on Thursday. “I saw his comments, and I think what I would say is that I’m doing my best to follow the due process here,” he told Cyclingnews .

“I get that it’s a difficult situation. Given his concern for the reputation of the sport, I think it would be more sensible of him to raise his concerns in person or at least though the right channels as opposed to through the media.

Keep my head down

“I’m obviously doing everything I can to get this resolved as quickly as possible, and just trying to keep my head down.”

It is thought that any ban Froome does incur would not affect any of his achievements in the intervening period since he was notified of the failed test. If the case were to go on past the Giro d’Italia and Tour de France he could possibly win both safe in the knowledge the results would stand.

Meanwhile, Marcel Kittel took his first victory of the season during stage two of the Tirreno Adriatico on Thursday, winning a bunch sprint ahead of Peter Sagan and Giacomo Nizzolo. Meanwhile, it was confirmed Mark Cavendish suffered a broken rib after his crash during the opening stage.

– Guardian News and Media 2018

The Irish Times Logo
Commenting on The Irish Times has changed. To comment you must now be an Irish Times subscriber.
SUBSCRIBE
GO BACK
Error Image
The account details entered are not currently associated with an Irish Times subscription. Please subscribe to sign in to comment.
Comment Sign In

Forgot password?
The Irish Times Logo
Thank you
You should receive instructions for resetting your password. When you have reset your password, you can Sign In.
The Irish Times Logo
Please choose a screen name. This name will appear beside any comments you post. Your screen name should follow the standards set out in our community standards.
Screen Name Selection

Hello

Please choose a screen name. This name will appear beside any comments you post. Your screen name should follow the standards set out in our community standards.

The Irish Times Logo
Commenting on The Irish Times has changed. To comment you must now be an Irish Times subscriber.
SUBSCRIBE
Forgot Password
Please enter your email address so we can send you a link to reset your password.

Sign In

Your Comments
We reserve the right to remove any content at any time from this Community, including without limitation if it violates the Community Standards. We ask that you report content that you in good faith believe violates the above rules by clicking the Flag link next to the offending comment or by filling out this form. New comments are only accepted for 3 days from the date of publication.